On September 2, 2020, Octavus Consulting and DealForma will present their most recent data and trends on dealmaking across biopharma, device, diagnostics, and digital health. Healthcare and life sciences deal and venture activity through August 2020 has not slowed down despite the challenges thrown at business leaders globally.
We will review recent trends covering the following:
- R&D Partnerships by the Numbers – Deal Values and Activity
- M&A among Biopharma, Device, Diagnostics, and Digital Health Companies
- Venture Investments into Companies by Therapy Area and Technology
- Top 20 Deals signed through August 2020
Principal Consultant, Octavus Consulting
About Octavus Consulting:
Octavus is a boutique consulting company, engaged in comprehensive business research, market intelligence, market research and data analytics by providing support and outsourcing solutions to bio-pharma, medtech, diagnostics, digital health companies and healthcare start-ups.
DealForma helps biopharma business development analysts be better at industry research by providing them clean information and direct analyst support. Business development teams use the DealForma platform to prepare for partnering meetings, research deals, funding trends, technologies, products, and the therapeutic areas they care about. We built DealForma to provide high quality, comprehensive data from thousands of companies and industry sources all in carefully curated profiles in an easy-to-use interface.